NEU neuren pharmaceuticals limited

Lets talk ROW, page-7

  1. 1,437 Posts.
    lightbulb Created with Sketch. 381
    the company is primed for a take over. It's a bit hard to justify the price tag of over $10 a share given where we are now BUT Evans and Partners valuation of $7.6 a share seems more justifiable and realistic. It's about the premium for a suitor would pay (~120% to 150%)
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$15.75
Change
0.580(3.82%)
Mkt cap ! $1.960B
Open High Low Value Volume
$15.35 $15.92 $15.24 $8.664M 553.6K

Buyers (Bids)

No. Vol. Price($)
1 2000 $15.72
 

Sellers (Offers)

Price($) Vol. No.
$15.79 1471 2
View Market Depth
Last trade - 16.13pm 22/07/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.